Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 217, Issue 1, Pages -Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20191397
Keywords
-
Categories
Funding
- Deutsche Forschungsgemeinschaft [Strategy-EXC 2155, 39087428]
Ask authors/readers for more resources
The IL-17 cytokine family comprising IL-17A to IL-17F and receptor subunits IL-17RA to IL-17RE represents a genetically ancient intercellular network regulating local tissue homeostasis. Its pivotal role in antifungal defense and its central position in the pathogenesis of inflammatory diseases including psoriasis were discovered only relatively late in the early 2000s. Since the connection of dysregulated IL-17 and psoriasis pathogenesis turned out to be particularly evident, a number of monoclonal antibodies targeting IL-17 pathways have been approved and are used as first line treatment of moderate-to-severe plaque psoriasis and psoriatic arthritis, and further agents are currently in clinical development.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available